← All trials
NCT05133882
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 12, 2022
- Primary completion
- Jul 6, 2023
- Completion date
- Oct 18, 2024
- First posted
- Nov 24, 2021
- Last posted
- Nov 24, 2021
- Enrollment
- 133
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Sunshine Lake Pharma Co., Ltd.Lead sponsor
- Zhejiang UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.